CHRNA9 抗体
Quick Overview for CHRNA9 抗体 (ABIN7112723)
抗原
See all CHRNA9 抗体适用
宿主
克隆类型
标记
应用范围
-
-
原理
- CHRNA9 antibody
-
纯化方法
- Immunogen affinity purified
-
纯度
- ≥95 % as determined by SDS-PAGE
-
免疫原
- cholinergic receptor, nicotinic, alpha 9
-
亚型
- IgG
-
-
-
-
应用备注
- WB: 1:500-1:2000
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
- Avoid repeated freeze / thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- -20°C for 12 months
-
有效期
- 12 months
-
-
- CHRNA9 (Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9))
-
别名
- CHRNA9
-
背景
-
Synonyms: Neuronal acetylcholine receptor subunit alpha-9|Nicotinic acetylcholine receptor subunit alpha-9 (NACHR alpha-9)|CHRNA9|NACHRA9
Background: Ionotropic receptor with a probable role in the modulation of auditory stimuli. Agonist binding induces a conformation change that leads to the opening of an ion-conducting channel across the plasma membrane(PubMed:11752216, PubMed:25282151). The channel is permeable to a range of divalent cations including calcium, the influx of which may activate a potassium current which hyperpolarizes the cell membrane(PubMed:11752216, PubMed:25282151). In the ear, this may lead to a reduction in basilar membrane motion, altering the activity of auditory nerve fibers and reducing the range of dynamic hearing. This may protect against acoustic trauma. May also regulate keratinocyte adhesion(PubMed:11021840).
-
分子量
- 50-55 kDa
-
基因ID
- 55584
-
UniProt
- Q9UGM1
-
途径
- Sensory Perception of Sound
抗原
-